SCHEMBL6355569

SCHEMBL6355569

CCN(CC)c1ccc(NS(=O)(=O)c2ccc(C(=O)Nc3ccc(Br)cc3C(=O)O)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 2/20 0.52
GPR27 Q9NS67 4/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
GFER P55789 2/20 0.49
RPA1 P27694 1/20 0.49
SLC10A6 Q3KNW5 2/20 0.48
AVPR2 P30518 1/20 0.48
SLC10A2 Q12908 1/20 0.48
SLC10A1 Q14973 1/20 0.48
MAPT P10636 2/20 0.47
MAPK1 P28482 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 1/20 0.47
GAA P10253 1/20 0.47
KDM1A O60341 1/20 0.47
AKR1C2 P52895 1/20 0.46
AKR1C1 Q04828 1/20 0.46
KCNK2 O95069 1/20 0.46
KCNK10 P57789 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6351450 0.90 MEN1 (0.67) MEN1KMT2AGFERRPA1MAPT
SCHEMBL6353969 0.88 PTGES (0.61) MEN1KMT2AGFERRPA1MAPT
SCHEMBL6359829 0.88 KCNK2 (0.57) MEN1KMT2AMAPTMAPK1SMN1; SMN2
SCHEMBL6353520 0.87 RPA1 (0.68) MEN1KMT2AGFERRPA1MAPT
SCHEMBL6349460 0.87 MEN1 (0.60) METAP2GPR27MEN1KMT2AGFER
SCHEMBL6348358 0.86 METAP2 (0.71) METAP2GPR27MEN1KMT2AGFER
SCHEMBL6830237 0.85 RPA1 (0.47) METAP2MEN1KMT2AGFERRPA1
SCHEMBL6350610 0.85 MEN1 (0.69) METAP2GPR27MEN1KMT2AGFER
SCHEMBL6352359 0.84 METAP2 (0.71) METAP2GPR27MEN1KMT2AGFER
SCHEMBL6835804 0.81 RPA1 (0.46) METAP2GPR27MEN1KMT2AGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 METAP2 1269/4885GPR27 4331/4885MEN1 3274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.